Abstract
A 63-year-old man with polycystic kidney disease underwent kidney transplantation from his wife. Nine years later, after the first and second doses of the COVID-19 vaccination, he developed proteinuria, hematuria, and elevated C-reactive protein. Kidney biopsy 7 months after the initial appearance of proteinuria showed immunoglobulin (Ig)-G granular stain, predominantly IgG1, and spike formation in the glomerular basement membrane. Electron microscopy revealed mainly subepithelial deposits, which corresponds to membranous nephropathy (MN) stage 3 of the Ehrenreich–Churg classification indicating chronic disease, but it also showed electron-dense deposits and endothelial damage. Because a kidney biopsy was performed 1 h after renal transplantation and a biopsy of the patient’s native kidney showed intact glomeruli, atypical de novo posttransplant membranous nephropathy (MN) was diagnosed, and a close relationship with COVID-19 vaccination was assumed. Clinicians should consider the involvement of COVID-19 vaccination in de novo posttransplant MN with unclear pathogenesis.
Similar content being viewed by others
References
Leon J, Pérez-Sáez MJ, Batal I, Beck LH Jr, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV. Membranous nephropathy posttransplantation: an update of the pathophysiology and management. Transplantation. 2019;103(10):1990–2002.
Klomjit N, Alexander MP, Fervenza FC, Zoghby Z, Garg A, Hogan MC, Nasr SH, Minshar MA, Zand L. COVID-19 vaccination and glomerulonephritis. Kidney Int Rep. 2021;6(12):2969–78.
Ota Y, Kuroki R, Iwata M, Taira H, Matsuo S, Kamijo M, Muta K, Nishino T. Association between COVID-19 vaccination and relapse of glomerulonephritis. Clin Exp Nephrol. 2023;27(3):236–42.
Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;78(4):611–3.
Thammathiwat T, Chompuk L, Worawichawong S, Boonpucknavig V, Sirilak S, Pongcharoen S, Pichitsiri W, Kanjanabuch T. Membranous nephropathy following full-dose of inactivated SARS-CoV-2 virus vaccination: a case report and literature review. Vaccines (Basel). 2022;11(1):80.
Chavarot N, Padden M, Amrouche L, Malard S, Scemla A, Sberro-Soussan R, Léon J, Legendre C, Duong JP, Zuber J, Anglicheau D, Rabant M, Isnard P. De novo posttransplant membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient. Am J Transplant. 2022;22(12):3188–9.
Aydın MF, Yıldız A, Oruç A, Sezen M, Dilek K, Güllülü M, Yavuz M, Ersoy A. Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination. Kidney Int. 2021;100(2):464–5.
Da Y, Goh GH, Khatri P. A case of membranous nephropathy following Pfizer-BioNTech mRNA vaccination against COVID-19. Kidney Int. 2021;100(4):938–9.
Gueguen L, Loheac C, Saidani N, Khatchatourian L. Membranous nephropathy following anti-COVID-19 mRNA vaccination. Kidney Int. 2021;100(5):1140–1.
Nasr SH, Alexander MP, Cornell LD, Herrera LH, Fidler ME, Said SM, Zhang P, Larsen CP, Sethi S. Kidney biopsy findings in patients with COVID-19, kidney injury, and proteinuria. Am J Kidney Dis. 2021;77(3):465–8.
Nakagawa N, Maruyama S, Kashihara N, Narita I, Isaka Y. New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan. Clin Exp Nephrol. 2022;26(9):909–16.
Matsuzaki K, Aoki R, Nihei Y, Suzuki H, Kihara M, Yokoo T, Kashihara N, Narita I, Suzuki Y. Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan. Clin Exp Nephrol. 2022;26(4):316–22.
Author information
Authors and Affiliations
Contributions
Dr. Fukuda: study concept and design and data acquisition; Drs. Sawa, Suwabe: data analysis and interpretation; Drs. Ikuma, Mizuno, Oba, Sekine, Hasegawa, Yamanouchi: study supervision; Drs. Kono, Kinowaki, Ohashi, Yamaguchi: histological analysis; Drs. Nakamura, Miki, Yokoyama, Ishii: surgery; Dr. Ubara: critical revision of the manuscript for important intellectual content.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no competing financial interests or conflicts of interest to declare.
Ethical approval
This investigation was performed in accordance with the Declaration of Helsinki. The patient gave written informed consent for this case report to be published.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Fukuda, M., Yokoyama, T., Miki, K. et al. De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease. CEN Case Rep (2024). https://doi.org/10.1007/s13730-024-00864-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13730-024-00864-4